WOMEN FOUNDERS • May 23, 2026

Last reviewed: June 2026 by Annie Wright, LMFT

In short: Series A crunch anxiety is the founder’s experience of investor decisions as personal judgments on their worth, arriving at exactly the moment traction data makes the stakes feel existential.

Kira Has Counted the Treadmill Squeak for Nine Minutes

It’s 5:53 a.m. in the hotel gym in Menlo Park, and Kira’s feet hit the treadmill belt in a steady rhythm, punctuated by a faint squeak every fourth step. For nine minutes, she’s counted that squeak, a metronome for the rising tightness in her chest. The muted CNBC screen ahead flashes a chyron about an AI startup. Her former co-founder’s new employer. A quiet reminder of the fracture she’s still piecing together. A man in a Patagonia vest enters, nods “morning” without meeting her eyes, and settles onto the elliptical beside her. Her mind whispers, I am running on a treadmill in a hotel I cannot afford because the round has to close. My body is supposed to be the part of me that does not need this to close. My body is the loudest voice in the room right now and it is saying close.

That treadmill squeak is not just a mechanical quirk; it’s a brutal companion to Kira’s internal state. The physicality of running, muscles burning, lungs gasping, stands in stark contrast to the immobilizing weight of the Series A crunch pressing on her nervous system. This moment is a threshold, where the body, often overlooked in the fundraising narrative, becomes the primary messenger of threat. The repetitive sound anchors her racing thoughts, a somatic punctuation to the relentless calculus of runway, dilution, and board expectations. Her body’s insistence is not mere anxiety but the reverberation of chronic stress activating her hypothalamic-pituitary-adrenal (HPA) axis, as Robert Sapolsky, PhD, has described in his work on stress physiology.

Kira’s quiet vigil in the gym is also a solitary echo of the co-founder breakup six months prior, an event that fractured not only her partnership but her sense of safety in the startup ecosystem. The AI company on the screen is a ghost of what might have been, intensifying the implicit question in the Series A round: Is she enough on her own? The treadmill’s repetitive squeak mimics the internal loop of self-doubt and hypervigilance that many solo founders face, especially women who carry the compounded burden of proving their worth in a venture capital world that often reads numbers as character judgments.

In this early morning stillness, Kira’s body is both a battleground and a barometer. It refuses the dissociation often prescribed in entrepreneurial mythologies, where founders are urged to “” or “lean in harder.” Instead, her body demands recognition, its tightness, its noise, its insistence that this round is not simply a financial milestone but a referendum on her value as a founder and human being. This somatic reality is rarely spoken aloud in pitch meetings or board rooms but is central to the Series A psychology that shapes Kira’s experience.

Why the Series A Crunch Activates a Different Wound Than the Seed Raise Did

It’s 5:53 a.m. in the hotel gym in Menlo Park, and Kira’s feet hit the treadmill belt in a steady rhythm, punctuated by a faint squeak every fourth step, she’s counted it for nine minutes straight. The muted CNBC screen above her displays a chyron about an AI startup, the one her former co-founder now works for, a quiet reminder of the fracture behind her. A man in a Patagonia vest enters, hops on the elliptical, and offers a quick “morning” without breaking his gaze; Kira nods in return but doesn’t look away from the moving belt. Her mind tightens around the thought, “I am running on a treadmill in a hotel I cannot afford because the round has to close. My body is supposed to be the part of me that does not need this to close. My body is the loudest voice in the room right now and it is saying close.”

The Series A crunch awakens a wound that the seed raise only grazed. While seed fundraising often triggers fears about proving viability and survival, the Series A stakes are different: they tap into the core of identity fusion, where the founder’s self-worth is inseparable from the company’s valuation and future. This round demands not just proof of concept, but proof of permanence and scalability. The body’s stress response shifts accordingly, engaging the hypothalamic-pituitary-adrenal (HPA) axis with an intensity that reflects this existential threat. As Robert Sapolsky, PhD, explains, chronic activation of this system during critical milestones like Series A can dysregulate the nervous system, making the founder’s experience somatic as much as psychological.

In my work with founders, I see how this phase often reactivates early attachment wounds, particularly those related to conditional worth described by Alice Miller, PhD. The implicit message becomes: “If you don’t close this round, you are not enough.” This is far more than professional risk, it resonates like a childhood verdict, making the pressure feel personal and unrelenting. Unlike the seed round, which can feel like a hopeful beginning, the Series A feels like a referendum on the founder’s entire trajectory. It’s why the anxiety during this phase is not simply “” but a complex nervous system response layered with betrayal trauma and identity entanglement.

This is where the internal alarm system becomes both a warning and a weight. The body’s signals, tightness in the chest, disrupted sleep, gut knots, are not just noise but coded messages from the nervous system demanding attention and care. Recognizing this helps founders understand that their distress is not a failure of grit but a biological reaction to a deeply personal threat. For those seeking support, the Founders hub offers resources that honor this complexity, integrating somatic awareness with fundraising realities.

Ultimately, the Series A crunch forces a reckoning with the founder’s internal narrative about worth, success, and survival, making it a unique psychological and physiological experience distinct from earlier fundraising stages.

The Math of the Series A Specifically. Why It Reads as a Referendum on Founder Worth

It’s 5:53 a.m. in the hotel gym in Menlo Park, and Kira’s feet hit the treadmill belt in a steady rhythm, punctuated by a faint squeak every fourth step. She has counted it for nine minutes straight. The TV mounted on the wall is tuned to CNBC, muted, scrolling a chyron about an AI startup where her former co-founder now works. A man in a Patagonia vest enters, steps onto the elliptical, and murmurs “morning” without meeting her eyes; she nods in return. In the silence between breaths, Kira thinks: “I am running on a treadmill in a hotel I cannot afford because the round has to close. My body is supposed to be the part of me that does not need this to close. My body is the loudest voice in the room right now and it is saying close.”

The Series A round is not just a financial milestone; it’s a complex calculation where every percentage point, every valuation tick, and every investor term feels like a direct appraisal of the founder’s intrinsic worth. Unlike earlier seed rounds where enthusiasm and potential might carry the day, the Series A crunch demands hard evidence of traction, product-market fit, and scalable growth. The numbers become a mirror reflecting not only the company’s viability but the founder’s identity, competence, and legitimacy. This is why the math reads as a referendum on who the founder is, beyond spreadsheets and cap tables.

When founders face this intense scrutiny, the body’s nervous system, already taxed from months or years of relentless work, registers the experience as a threat to survival. The HPA axis activates, flooding with cortisol and adrenaline, which heightens vigilance and amplifies the sensation that everything hinges on this moment. Robert Sapolsky, PhD, explains how chronic stress rewires the brain’s response to perceived evaluation, making it impossible to separate self-worth from external validation. For a founder like Kira, this means the round’s closure is not just a business outcome; it’s a visceral, embodied judgment.

In my work with women founders, I see how this dynamic deepens the identity merger described in FC1, where the company’s fate and the founder’s sense of self become indistinguishable. The math of the Series A is unforgiving in its precision, but the psychological toll comes from the implicit message it sends: your value is quantifiable and on the line. This is why the Series A psychology differs so markedly from earlier stages and requires a therapeutic approach that addresses the body’s alarm system alongside the cap table.

For founders navigating this terrain, the Founders hub offers resources to disentangle identity from valuation and build resilience that honors the full complexity of this experience.

The Three Body Symptoms That Show Up in the Series A Window (And What They Mean)

It’s 5:53 a.m. in the hotel gym in Menlo Park, and Kira’s feet hit the treadmill belt in a steady rhythm, punctuated by a faint squeak every fourth step. She has counted that squeak for nine minutes straight. The TV mounted on the wall plays CNBC, muted, with a chyron scrolling about an AI startup her former co-founder now leads. A man in a Patagonia vest enters, steps onto the elliptical without looking her way, and says “morning.” She nods quietly. Inside, she thinks: “I am running on a treadmill in a hotel I cannot afford because the round has to close. My body is supposed to be the part of me that does not need this to close. My body is the loudest voice in the room right now and it is saying close.”

In the Series A window, the body often broadcasts three distinct somatic signals that founders, especially solo founders like Kira, experience as urgent and unignorable. First, there is the hypervigilant tension: muscles clenched, jaw tight, a constant readiness for the next crisis. This is the sympathetic nervous system’s fight-or-flight mode, triggered by chronic threat perception that Robert Sapolsky, PhD, describes as allostatic load, a wear-and-tear effect of sustained stress on the body. It’s not just anxiety; it’s a biological state that can impair decision-making and creativity when unregulated.

Second, the collapse or shutdown sensation often follows, a dorsal vagal freeze response that Stephen Porges, PhD, associates with immobilization under overwhelming threat. Founders report moments where their limbs feel heavy, their energy drains, or their mind blanks out during critical conversations or pitch meetings. This state signals the nervous system’s protective mechanism, but it can feel like a betrayal of the very drive that got them this far.

Third, there’s a somatic ache of loss and loneliness, a subtle but persistent body memory of childhood emotional neglect, what clinicians call the “undermothered” wound. This ache reflects the absence of attuned emotional support, as described by Alice Miller, PhD, and can intensify the feeling that the round’s outcome is a personal verdict. For Kira, these three body symptoms are not separate; they intertwine, creating a feedback loop that amplifies the Series A and the sense that her worth is on trial.

Understanding these signals is vital. The body is not merely reacting, it is communicating. Recognizing the tension, shutdown, and ache as messages rather than failures allows a founder to engage with her experience more compassionately, creating space to respond rather than react. This somatic literacy is a cornerstone of the Founders hub, where the interplay between body and capital strategy is explored in depth.

The Specific Hazard of the “Hot Round” That Goes Cold. And Why It Feels Like a Childhood Wound

It’s 5:53 a.m. in the hotel gym in Menlo Park, and Kira’s feet hit the treadmill belt in a steady rhythm, punctuated by a faint squeak every fourth step. She’s counted the squeak for nine minutes straight. The muted CNBC screen in front of her flashes a chyron about the AI startup her co-founder left to join. A man in a Patagonia vest enters, steps onto the elliptical without glancing her way, and says “morning.” Kira nods back, her mind racing: I am running on a treadmill in a hotel I cannot afford because the round has to close.

The “hot round” that suddenly cools is a unique trauma for founders. Unlike the seed raise, which often feels like planting a hopeful seed in uncertain soil, a Series A round is loaded with expectation and a timeline that feels like a verdict on your very being. When the momentum stalls, it triggers a profound wound akin to the childhood experience of conditional worth. Alice Miller, PhD, described this as the relentless internal message that love and acceptance depend on performance.

In my work with founders, I see how this experience activates the hypothalamic-pituitary-adrenal (HPA) axis in a way that mirrors chronic childhood stress. Robert Sapolsky, PhD, explains how unpredictable threat leads to dysregulated stress responses, and for founders in this liminal space, the body’s alarm system becomes hypervigilant. The “hot round” that cools becomes a betrayal of expectation and trust, intensifying the allostatic load on the nervous system. This is why the somatic experience during a stalled Series A feels less like a business hiccup and more like a reopening of old wounds.

For women founders like Kira, this moment is compounded by the internalized narratives of self-sufficiency and the need to “prove” worthiness through achievement, a pattern many carry from childhood emotional neglect. The body’s loud demand to “close” is not just financial; it’s a plea for survival, for belonging, and for the restoration of fractured identity. Navigating this requires more than just strategic pivots, it calls for a recognition of the deep relational and somatic layers intertwined with the fundraising process, an approach that can be supported through tailored therapy and executive coaching.

Both/And: The Round Is a Capital Event AND The Round Is Reading As a Verdict

It’s 5:53 a.m. in the hotel gym in Menlo Park. Kira’s feet hit the treadmill belt in a steady rhythm, punctuated by a faint squeak every fourth step, a sound she’s counted for nine minutes straight. The muted CNBC screen ahead flashes a chyron about the AI startup her former co-founder now leads, a quiet reminder of the path not taken. A man in a Patagonia vest enters, steps onto the elliptical, offers a casual “morning” without meeting her eyes; she nods back, focused on the miles ahead.

The Series A round stands as a clear-cut capital event: dollars exchanged, ownership percentages negotiated, the runway extended. It’s tangible, measurable, and undeniably consequential. Yet simultaneously, for founders like Kira, the round reads as a verdict, not just on the business, but on their very worth as a founder, as a leader, and as a person. This duality creates a psychic bind where the success of the funding feels inseparable from personal validation or invalidation. The stakes aren’t only financial; they ripple through identity and nervous system alike.

In my work with women founders navigating this stage, I see how the round’s outcome becomes a mirror reflecting internalized childhood narratives about worthiness and acceptance, echoing concepts from Alice Miller, PhD’s research on conditional worth. The body’s stress response, the HPA axis, as described by Robert Sapolsky, PhD, amplifies these feelings, translating financial uncertainty into somatic alarms that can feel overwhelming or immobilizing.

This “both/and” reality means founders must hold the tension of the round as a critical business milestone while also witnessing the emotional and somatic verdict it seems to pronounce. Recognizing this complexity is essential to avoid collapsing under the weight of self-judgment or dissociation. It’s why therapeutic and coaching spaces, like the executive coaching I provide, create room for founders to integrate these experiences without losing themselves in the process.

Kira’s treadmill moment is a microcosm of this paradox, her body demanding closure, her mind wrestling with the implications. The round is capital. The round is verdict. And holding both truths simultaneously is a form of resilience that often goes unspoken but is deeply necessary.

The Practices That Get a Founder Through the Series A Crunch Without Becoming a Different Person

It’s 5:53 a.m. in the hotel gym in Menlo Park, and Kira’s feet hit the treadmill belt in a steady rhythm, punctuated by a faint squeak every fourth step. She’s been counting that squeak for nine minutes now, a metronome in the quiet room. The TV mounted on the wall is tuned to CNBC, muted, the chyron scrolling news about the AI startup her former co-founder joined after their breakup. A man in a Patagonia vest steps in, nods “morning” without looking her way, and starts up the elliptical.

In my work with founders at this crossroads, the practices that sustain a sense of self through the Series A crunch are less about willpower and more about attuning to the body’s signals, a critical shift from the usual CEO script. The nervous system, as Robert Sapolsky, PhD, explains, cannot be reasoned with; it must be regulated. Founders who integrate somatic awareness with strategic action create a container that holds their identity separate from the round’s outcome.

Practices like establishing micro-boundaries around rest and movement, even in a cramped hotel gym, help to maintain a baseline of regulation. Kira’s counting of the treadmill squeak is a subtle form of grounding, a somatic anchor that keeps her present amid the swirling mental noise of term sheets and investor calls. It’s a practice that honors the body’s voice instead of overriding it. When founders tolerate these sensations with curiosity rather than judgment, they prevent the identity merger that can make the round feel like a referendum on their worth.

Engaging in reflective conversations with trusted peers or coaches, such as those found in my Founders hub,provides a relational container that counters isolation and fawning responses. This relational safety allows the founder to name the fears and distinguish between the company’s trajectory and their personal value. It’s the difference between carrying the round and being carried by it.

Ultimately, the founders who navigate this phase without becoming unrecognizable to themselves hold both the capital event and their complex humanity simultaneously. They cultivate a leadership presence that is resilient not because it denies vulnerability, but because it is attuned to the full spectrum of experience, the nervous system, the mind, and the heart all intact.

The Founders Who Closed and the Founders Who Did Not. What Their Bodies Did Differently

It’s 5:53 a.m. in the Menlo Park hotel gym. Kira’s feet hit the treadmill belt, marking a faint squeak every fourth step, she’s counted it for nine minutes straight. The muted CNBC screen shows a chyron about an AI startup where her former co-founder now works. A man in a Patagonia vest enters, steps onto the elliptical, and offers a quick “morning” without breaking his gaze; she nods back. In the quiet hum of machines, Kira thinks, “I am running on a treadmill in a hotel I cannot afford because the round has to close.

What separates the founders who close their Series A from those who don’t is not just strategy or pitch polish, it’s how their bodies register and respond to the existential threat of the crunch. The founders who closed had nervous systems that, while taxed, remained dynamically regulated enough to engage with the high-stakes stress without collapsing or fragmenting. Their bodies, as Bessel van der Kolk, MD, has shown, held the trauma without becoming trapped in fight, flight, or freeze.

Conversely, founders who did not close often experienced a dysregulated HPA axis, as Robert Sapolsky, PhD, details, where chronic stress tipped the balance toward exhaustion or hyperarousal. Their bodies either locked into a dorsal vagal shutdown, numbness, dissociation, collapse, or a frantic sympathetic surge, marked by tremors, shallow breathing, and scattered attention. This somatic response, rooted deeply in childhood emotional neglect and betrayal trauma, sabotaged their ability to “hold” the moment, no matter how strong their intellectual preparation.

Kira’s interior experience on the treadmill captures this somatic truth: the body is not a neutral vessel but the primary interpreter of worth and safety. The founders who succeed in closing have learned, often through therapy or executive coaching, how to listen to these bodily signals without letting them dictate the narrative. They cultivate a somatic awareness that allows them to track when they’re shifting into protective states and develop practices to reorient toward presence and agency. This is not about ignoring the body’s alarm system but honoring it as a guide, a compass in the emotional wilderness of fundraising.

For women founders, especially those carrying the weight of relational wounds, this somatic literacy becomes part of the capital strategy itself. It’s why I encourage founders in the Founders hub to prioritize their nervous system regulation alongside their pitch decks. Because when the round feels like a referendum on your worth, the body’s voice is not just noise, it’s the final arbiter of whether you can stay in the room long enough to close.

References

Peer-Reviewed Research (Vancouver)

1. Porges SW. Polyvagal Theory: Current Status, Clinical Applications, and Future Directions. Clin Neuropsychiatry. 2025;22(3):169-184. doi:10.36131/cnfioritieditore20250301. PMID: 40735382.
2. van der Kolk BA, Wang JB, Yehuda R, Bedrosian L, Coker AR, Harrison C, et al. Effects of MDMA-assisted therapy for PTSD on self-experience. PLoS One. 2024;19(1):e0295926. doi:10.1371/journal.pone.0295926. PMID: 38198456.

Books & Cultural Sources (Chicago Author-Date)

• Angelou, Maya. I Know Why the Caged Bird Sings. Random House, 1969.
• Dickinson, Emily. The complete poems of Emily Dickinson. Little, Brown, 1960.

Medical Disclaimer